Advertisement
Business

Drug company won’t cut its $750-per-pill price; rival’s 99-cent version getting snatched up

Turing Pharmaceuticals

After weeks of criticism from patients, doctors and even other drugmakers for hiking a life-saving medicine’s price more than fiftyfold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

(Craig Ruttle / Associated Press)

After weeks of criticism from patients, doctors and even other drugmakers for hiking a life-saving medicine’s price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

Instead, the small biotech company says it’s reducing the price for hospitals by up to 50% for its Daraprim, which treats a rare parasitic infection that mainly strikes pregnant women and HIV patients.

The 62-year-old drug had no competition until a furor over the gigantic price hike erupted, triggering multiple government investigations.

Then a pharmacy that compounds prescription drugs for individual patients stepped in and started selling a capsule version for 99 cents. Imprimis Pharmaceuticals says orders are pouring in from doctors and it says it has dispensed more than 2,500 capsules in barely a month.

Advertisement

SIGN UP for the free California Inc. business newsletter >>

MORE FROM BUSINESS

New-home sales rebound in October

Average rate on 30-year mortgage slides to 3.95%

Advertisement

Stocks edge higher as trading winds down before Thanksgiving


Newsletters
Get our weekly California Inc. newsletter
Advertisement